3.40 USD
↘ 0.12 (3.41%)AT CLOSE (11:59 AM EDT)
Mannkind Corporation
MNKDNASDAQ • USD
3.45
↗ 0.05 (1.44%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
3.45
↗ 0.05 (1.44%)
Market: CLOSED
Open?$3.53
High?$3.53
Low?$3.39
Prev. Close?$3.52
Volume?3.2M
Avg. Volume?6.6M
VWAP?$3.45
Rel. Volume?0.49x
Bid / Ask
Bid?$2.94 × 100
Ask?$3.94 × 100
Spread?$1.00
Midpoint?$3.44
Valuation & Ratios
Market Cap?1.1B
Shares Out?309.0M
Float?299.1M
Float %?97.4%
P/E Ratio?N/A
P/B Ratio?-17.75
EPS?-$0.08
Dividend?0.00%
Ex-Dividend?N/A
Mannkind Corporation (MNKD) trades at $3.40 per share. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (40.4%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place MNKD at a fair price relative to peers.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Employees
592
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2004-07-28
Address
1 CASPER STREET
DANBURY, CT 06810
Phone: 818-661-5000
DANBURY, CT 06810
Phone: 818-661-5000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?35
Short Sent.?40
Piotroski F-Score?3/9Weak
Altman Z-Score?-4.50Distress
Confidence?66%Moderate
Short InterestElevated
Short % of Float?9.83%Elevated
Short Interest?29.4M
Days to Cover?3.4
Free Float299.1M
Avg Daily Volume8.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.87Adequate
Quick Ratio?1.50Adequate
Cash Ratio?0.39Low
Debt/Equity?-8.22Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-17.75CHEAP▾
S&P97
P/S?2.91CHEAP▾
Peers100
S&P52
P/FCF?79.9PRICEY▾
Peers100
S&P3
EV/EBITDA?42.0HIGH▾
Peers100
S&P3
EV/Sales?4.11FAIR▾
Peers100
S&P45
Returns & Efficiency
ROE?40.4%STRONG▾
Peers50
S&P88
ROA?-3.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$13.2M
Enterprise Value?$1.5B
Fundamentals ratios updated end of day